Comprehensive Study Notes on Axon Guidance, Glia, and Myelination
Advective cues in the spinal cord and midline crossing
Focus area: dorsal-origin axons in the spinal cord projecting ventrally toward the floor plate; goal is to understand how these axons navigate and cross the midline (the floor plate) and the cues that guide their pathfinding.
Key midline cue at the floor plate: Netrin (a soluble cue) secreted in this region.
Dorsal-origin axons discussed: contraleral/contra-axons that originate dorsally and extend axon processes ventrally toward the floor plate, crossing the midline and then not recrossing.
Sonic hedgehog (Shh) and floor plate signaling: Shh is important for motor neuron specification; floor plate is enriched in netrin signaling that guides these axons.
Core idea: Netin signaling is central for midline attraction and pathfinding of this axon group; receptors and downstream cytoskeletal changes translate extracellular cues into growth cone movement.
Netrin signaling and growth cone dynamics
Netrin is soluble and concentrated at the floor plate; acts as an attractive cue for certain growth cones.
Receptors and interactions: netrin receptors (e.g., DCC and presumably related receptors) bind netrin; ligand is enriched in floor plate regions.
Cytoskeletal consequences: attraction to netrin is associated with actin remodeling in the growth cone, involving Rac (a small GTPase) promoting protrusive structures and directionality.
Question raised in lecture: when a cue is attractive, which GTPase dominates—Rac or Rho? Answer given: Rac (promotes protrusion toward the cue); Rho often associated with contractility and collapse in other contexts.
Concept of integration: axons use knowledge of different cues to decide where to grow and how to turn; the same pathway needs to integrate signals from multiple sources to generate directed growth.
Practical teaching point: even if you don’t remember all molecule names, you should know which cues activate which kind of cytoskeletal response (e.g., attractive cue -> Rac activation -> forward growth).
Chemoattraction, chemorepulsion, and the two-state navigation model
Early attractive phase: the axon grows toward regions with high netrin concentration (chemoattraction).
Why doesn’t the axon stop at the first attractant cue? There is a change in sensitivity along the path; susceptibility to the chemoattractant changes, enabling continued growth beyond the initial attractant zone.
Diversion and repulsion: at a later stage, a repellent cue (e.g., Slit) can influence the same axons to divert growth away from the floor plate in specific directions.
Local balance model: axonal guidance is regulated by a local balance between attractive (netrin) and repellent (Slit, other cues) signals; the relative levels and receptor availability determine turning decisions.
Example of a downstream signaling pattern: a shift from netrin attraction to a rebalancing of signals at subsequent decision points, enabling correct trajectory outcomes.
Concept of plasticity in guidance: the axon’s responsiveness can shift due to intracellular second messengers and receptor trafficking (see COM discussion below).
Netrin signaling and intracellular second messengers
Second messengers associated with netrin signaling:
Cyclic AMP (cAMP): increases downstream signaling to promote attractive responses in some growth cones.
The discussion notes a link between netrin attraction and signaling molecules that bias growth toward the cue.
Emphasis on how signaling directionality is not fixed but context-dependent, enabling flexible pathfinding in a dynamic environment.
Receptor–ligand interactions and receptor availability
Concept: receptor availability on the growth cone surface is a critical determinant of responsiveness to cues.
Mechanistic idea introduced: a regulatory protein (referred to as COM in the lecture) modulates the trafficking of receptors, shuttling them away from the membrane toward late endosomes/lysosomes for degradation.
Consequence: even if mRNA for a receptor is present, protein may not reach the membrane in adequate amounts to respond to ligand signaling if COM-mediated trafficking is active.
Demonstration context: the same principle can apply to receptors for other cues (e.g., netrin) and helps explain why signaling can be context-dependent and temporally dynamic.
Semaphorins, plexins, and neuropilins in axon guidance
Semaphorins act as guidance cues that can repel or modify growth cone direction.
Core receptor complexes: Plexin family receptors and neuropilins (co-receptors) mediate semaphorin signaling; some semaphorins are secreted (soluble) while others are membrane-bound.
Receptor partnerships: semaphorin signaling often requires interaction with Plexins and Neuropilins; context (secreted vs membrane-bound) influences the signaling outcome.
Functional note: semaphorins can act as short-range retractors or long-range guidance cues depending on their form and receptor composition.
Visual/memory cue from the lecture: the term "semaphores" was used as a metaphor for signaling that stops movement, analogous to traffic lights affecting growth cone dynamics.
Glial cells: diversity, origins, and roles in development
Glia are diverse and intermingled with neurons from early development; single-cell transcriptomics reveals heterogeneity beyond traditional categories.
Glial roles overview: structural/trophic support for neurons, modulators of nerve function, and active participants in development and pathology.
Microglia:
Origin: hematopoietic lineage (mesodermal) rather than neural plate; colonize the brain early in development.
Role: immune surveillance and synaptic pruning via phagocytosis; can tag and remove synapses, a process implicated in development and neuropathology.
Astrocytes:
Broadly supportive and signaling roles; regulate neurotransmitter uptake, ion balance, and synaptic milieu; may influence neuronal activity and plasticity.
Experimental note: interventions with human astrocytes in mouse brains suggested possible behavioral changes (e.g., exploratory behavior), illustrating functional influence of glia on neural circuits.
Oligodendrocytes (CNS myelinating glia):
Progenitors (OPCs) arise in the CNS; they differentiate into myelinating oligodendrocytes and can form multiple internodes on several axons.
Differences from Schwann cells (PNS): oligodendrocytes can myelinate multiple axons and multiple internodes per cell; Schwann cells typically myelinate a single axon segment.
Myelin structure and ECM interactions: basal lamina and laminin-rich ECM are crucial in the PNS (Schwann) environment for myelination; CNS myelination relies on different ECM cues and lacks a basal lamina like PNS.
Schwann cells (PNS myelinating glia):
Originate from neural crest; initially proliferate in association with axons, then sort axons to form dedicated myelinating relationships.
Each Schwann cell typically myelinates a single axon segment; non-myelinating Schwann cells can ensheathe multiple small-caliber axons.
Basal lamina and ECM interactions (e.g., laminin) are essential for Schwann cell myelination; absence of ECM cues disrupts myelination.
Neural crest and gliogenesis in the PNS:
First migratory wave yields melanocytes (pigment cells) and other derivatives; second wave yields Schwann cells and peripheral glia.
Epithelial-to-mesenchymal transitions drive early neural crest migration; later transitions contribute to Schwann cell development.
Myelination: central vs peripheral glia, and key signaling concepts
Core idea: myelination evolves in two systems independently (CNS = oligodendrocytes; PNS = Schwann cells) but with shared themes:
Myelin grows from the inside out, around the axon, with the inner layers wrapping first.
Schwann cells: onemyelin per axon; oligodendrocytes: multiple myelin segments on one or more axons.
Axon diameter influences myelination decisions; a threshold around 1 μm helps determine if a Schwann cell will myelinate; oligodendrocytes apply their myelination program more flexibly across axons.
Neuregulin-1 (NRG1) and ErbB signaling as a central switch for Schwann cells:
Neuregulin-1 (NRG1) exists in multiple isoforms; Type III NRG1 (membrane-tethered) is particularly important for signaling to Schwann cells.
Receptors: ErbB2 and ErbB3 form a receptor dimer; ErbB2 provides the signaling kinase activity, ErbB3 binds the ligand but has impaired kinase activity, so dimerization is necessary for signaling.
Threshold and dose-dependence: the level of membrane-bound NRG1 Type III on axons determines whether Schwann cells initiate myelination and influences the thickness of the resulting myelin (G-ratio dependent).
Experimental genetics: loss of NRG1/ERBB signaling abolishes myelination; rescue by ectopic expression of the missing factor can restore myelination in otherwise non-myelinating axons.
G ratio (optimal myelination quality):
Definition: where daxi is inner axon diameter and Dax+myelin is the outer diameter including myelin.
Optimal range is species- and tract-dependent, but generally around 0.6–0.7 in CNS tracts; deviations (too high or too low) impair conduction efficiency.
Autonomous vs conditional specification in myelination:
Schwann cells: myelination is conditional on axonal signals (axon-dependent); the Schwann cell needs to sense axonal cues to begin myelination.
Oligodendrocytes: display a more autonomous onset of myelination in response to a growth-factor-rich environment (e.g., in culture with appropriate cues, they can initiate myelination without direct axonal contact initially).
This distinction informs true developmental biology: Schwann cell myelination is highly axon-dependent, while oligodendrocyte myelination is more timer- and growth-factor-regulated, often described as autonomous with an intrinsic developmental timer.
Key transcription factors and gliogenesis timeline:
OLIG1/OLIG2: pivotal for oligodendrocyte lineage specification; the same ventral domain that generates motor neurons also gives rise to oligodendrocyte precursors early in development.
SOX9 and SOX10: gliogenic transcription factors; upregulated to drive glial fates after neurogenesis.
Notch signaling, plus additional factors, shape transitions: neuronal progenitors first generate neurons, then transition to glia (gliogenesis) with waves reflecting distinct lineages (motor neurons first, then oligodendrocytes; V2 interneurons then astrocytes in some domains).
In vitro myelination culture system (DRG-Schwann cell model):
Co-cultures of embryonic dorsal root ganglion (DRG) neurons with Schwann cells can recapitulate myelination in vitro when supplemented with vitamin C (assists extracellular matrix remodeling and myelin assembly).
Experimental manipulations show necessity and sufficiency of NRG1 signaling for myelination in this system.
Loss-of-function and rescue experiments demonstrate that neurite-derived NRG1 is necessary for myelination; reintroduction rescues myelination in otherwise non-myelinating cultures.
Important experimental paradigms:
Loss of function: deleting NRG1 or its receptors prevents myelination; demonstrates necessity.
Rescue experiments: reintroducing NRG1 restores myelination, demonstrating sufficiency in the right context or with the right axon–glial interaction.
Ectopic (gain-of-function) experiments: forcing expression of NRG1 in neurons that normally don’t get myelinated can drive ectopic myelination, illustrating sufficiency in that context.
Developmental waves and transcriptional timing in gliogenesis
Oligodendrocyte development follows a defined sequence driven by transcription factors and morphogens:
PROGENITORS: neuroepithelial progenitors near the ventral domain generate motor neurons first, then produce oligodendrocyte progenitors (OPCs).
GLIAL WAVES: gliogenesis follows neurogenesis with domains producing different glial lineages (e.g., V2 interneurons → astrocytes in some regions).
OLIG1/OLIG2 drive oligodendrocyte specification; OLIG1/2 knockout shifts fate away from oligodendrocytes toward other lineages.
The two-wave concept and timing (rapidly summarized):
Early wave: motor neurons generated from ventral neural tube domains; followed by oligodendrocyte progenitors.
Later wave: astrocytes and other glial subtypes arise from similar domains with distinct transcriptional programs.
An intrinsic timer model for oligodendrocyte maturation:
A counting component (PDGF signaling) regulates how many divisions progenitors undergo before initiating terminal differentiation and myelination.
An effector component (involving thyroid hormone T3) pushes cells from oligodendrocyte progenitors into mature, myelinating oligodendrocytes.
PDGF supports proliferation; absence of T3 or insufficient PDGF signaling delays differentiation or shifts outcomes.
Clinical relevance: demyelinating disease and glial contributions
Multiple sclerosis (MS) as a CNS demyelinating disease:
Demyelination disrupts saltatory conduction, reduces signaling speed, and can lead to axonal degeneration if prolonged.
Optic neuritis can be an early symptom due to demyelination in the optic nerve (myelinated in the CNS).
Remyelination can occur but often declines with time; chronic demyelination contributes to neurodegeneration.
Peripheral nervous system demyelination:
Charcot–Marie–Tooth disease and other peripheral neuropathies reflect demyelination in the PNS; Schwann cells are central to remyelination in the PNS.
Glial metabolism and trophic support:
Oligodendrocytes provide metabolic support to axons (e.g., lactate shuttle); disruption can contribute to axonal vulnerability and degeneration.
Emerging research links glial metabolic support to neuronal health and disease outcomes.
Microglial synaptic pruning and neural circuit refinement:
Microglia prune synapses during development; dysregulation may contribute to neurodevelopmental or neurodegenerative disorders.
Perineuronal nets (PNNs) and extracellular matrix (ECM) remodeling:
PNNs and ECM components influence synaptic remodeling; glial activity and activity-dependent plasticity intersect with ECM dynamics.
Real-world relevance and translational angles:
Understanding nodal structure, myelin thickness (G ratio), and axon diameter relationships informs approaches to neuroregenerative therapies.
Therapeutic strategies targeting NRG1–ErbB signaling, PDGF/T3 timing, or ECM cues hold potential to promote remyelination and repair in MS or peripheral neuropathies.
Key definitions and concepts (glossary)
Netirin signaling and receptors: Netin acts as a chemoattractant/cue via receptors on growth cones (e.g., DCC; other netrin receptors).
Slit–Robo signaling: Slit acts as a midline repellent; Robo receptors on axons respond to Slit to prevent recrossing the midline.
Plexins and Neuropilins: Semaphorin receptors; plexins are the signaling core; neuropilins act as co-receptors; semaphorins can be secreted or bound to membranes.
Neuregulin-1 (NRG1): A family of growth factors with multiple isoforms; Type III is membrane-bound and key for Schwann cell myelination signaling.
ErbB receptors: Receptor tyrosine kinases (ErbB2, ErbB3) that form heterodimers to transduce Neuregulin signals.
PDGF: Platelet-derived growth factor; a mitogen and signaling cue for oligodendrocyte progenitors and glial development; involved in the proliferation/timing of oligodendrocyte maturation.
Thyroid hormone (T3): Hormonal input that promotes oligodendrocyte maturation and myelination in conjunction with PDGF signaling.
G ratio: The axon diameter to myelinated diameter ratio, a measure of myelin thickness relative to axon size: .
Basal lamina and laminin: ECM components crucial for Schwann cell–axon interactions and myelination in the PNS.
Perineuronal nets (PNNs): ECM structures surrounding neurons that influence plasticity and synaptic remodeling.
Oligodendrocyte progenitor cells (OPCs): Precursor cells that differentiate into myelinating oligodendrocytes in the CNS.
Schwann cells: Myelinating glia of the PNS; each typically myelinates a single axon segment; originate from neural crest.
Myelination autonomy vs conditionality:
Autonomous myelination: oligodendrocytes can initiate myelination under permissive culture/conditions without direct axon signaling.
Conditional myelination: Schwann cells require axonal cues to begin myelination.
Connections to foundational principles and real-world relevance
Integration of signaling pathways: Development relies on cue integration (netrin, Slit, semaphorins, growth factors) and linkages to intracellular second messengers (cAMP, Rac) to drive growth cone decisions.
Temporal sequencing and lineage decisions: Across CNS and PNS, neural progenitors follow a progression (neuron -> oligodendrocyte/astrocyte) guided by transcription factors (OLIG1/2, SOX9/10) and morphogens, illustrating how timing and transcriptional programs shape cell fate.
Structure–function relationships in myelination: The geometry of myelin (G ratio), the number of internodes per oligodendrocyte, and ECM environments influence conduction velocity and circuit function, with implications for learning and plasticity.
Disease relevance: Demyelinating diseases (MS, Charcot–Marie–Tooth) illustrate how changes in glial support, myelin integrity, and axon–glia signaling translate to functional deficits; understanding glial biology opens avenues for regenerative therapies.
Experimental design principles highlighted in lecture: Loss-of-function, rescue, and gain-of-function experiments are used to distinguish necessity and sufficiency in signaling pathways; culture systems allow dissection of autonomous vs conditional aspects of glial differentiation and myelination.
Quick recap and study cues
Midline crossing in the spinal cord is guided by netrin (attractive cue) with Slit–Robo signaling shaping midline crossing and re-crossing behavior.
Growth cone responses depend on cytoskeletal regulators (Rac promotes attraction via actin remodeling; Rho/ROCK linked to contractility in other contexts).
Semaphorins add complexity as either attractive or repulsive cues via Plexin/Neuropilin receptors; their signaling forms can be soluble or membrane-bound.
COM (a trafficking regulator) can control receptor availability on the growth cone surface, modulating sensitivity to cues.
Glia are diverse and essential players in nervous system development, function, and disease; microglia prune synapses; astrocytes modulate neurotransmission and support; oligodendrocytes and Schwann cells myelinate CNS and PNS, respectively.
Neuregulin-1 Type III signaling through ErbB2/ErbB3 is a central switch for Schwann cell myelination; dose of NRG1 and axon caliber influence myelin thickness (G ratio).
CNS vs PNS myelination differ in cellular architecture, ECM requirements, and myelination strategies, explaining why remyelination strategies differ across CNS and PNS.
The nervous system uses intrinsic timers and transcriptional programs to regulate oligodendrocyte maturation (PDGF timing and T3 input) independent of immediate axon contact in some contexts.
Disease links to glia and myelin biology emphasize the therapeutic potential of targeting glial signaling and metabolism to preserve or restore neural function.
If you want, I can tailor these notes to a particular exam format (e.g., cue cards, concept maps, or a concise outline) or expand any section with more detail and diagrams.